Supplemental Information from hPCL3s Promotes Hepatocellular Carcinoma Metastasis by Activating β-Catenin Signaling

Authors:
  • ZCZhen Cai
    Zhen Cai
  • ZQZhen-Yu Qian
    Zhen-Yu Qian
  • HJHao Jiang
    Hao Jiang
  • NMNing Ma
    Ning Ma
  • ZLZhi Li
    Zhi Li
  • LLLi-Yu Liu
    Li-Yu Liu
  • XRXin-Xin Ren
    Xin-Xin Ren
  • YSYu-Rong Shang
    Yu-Rong Shang
  • JWJing-Jing Wang
    Jing-Jing Wang
  • JLJing-Jing Li
    Jing-Jing Li
  • DLDong-Ping Liu
    Dong-Ping Liu
  • XZXiu-Ping Zhang
    Xiu-Ping Zhang

Abstract
The supplementary infomation containing Figure legends, five supplemental figures and 3 supplemental tables. Figure S1 The higher expression of hPCL3s correlated with the poor survival of HCC patients. Figure S2 hPCL3s did not promote the tumorigenesis in vivo. Figure S3 The effects of hPCL3s on the growth of Hep3B, Huh7 and PVTT cells in a 48-hour time window were evaluated using MTT assay. Figure S4 Screening the signal pathways affected by hPCL3s. Figure S5 The AAV delivered Flag-hPCL3s was dominantly expressed in the liver. Table S1 Primer sequences. Table S2 The correlation between the expression of hPCL3s and clinical feature (Tissue array 2). Table S3 Microarray data.